Alterations in daily sequencing of axitinib and fractionated radiotherapy do not affect tumor growth inhibition or pathophysiological response.
about
Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.Axitinib sensitization of high Single Dose Radiotherapy.
P2860
Alterations in daily sequencing of axitinib and fractionated radiotherapy do not affect tumor growth inhibition or pathophysiological response.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Alterations in daily sequencin ...... r pathophysiological response.
@en
Alterations in daily sequencin ...... r pathophysiological response.
@nl
type
label
Alterations in daily sequencin ...... r pathophysiological response.
@en
Alterations in daily sequencin ...... r pathophysiological response.
@nl
prefLabel
Alterations in daily sequencin ...... r pathophysiological response.
@en
Alterations in daily sequencin ...... r pathophysiological response.
@nl
P2860
P356
P1433
P1476
Alterations in daily sequencin ...... r pathophysiological response.
@en
P2093
Bruce M Fenton
Scott F Paoni
P2860
P304
P356
10.1667/RR1595.1
P577
2009-05-01T00:00:00Z